Annals of Internal Medicine最新文献

筛选
英文 中文
All about alpha-gal syndrome from early days to now. 从早期到现在都是关于阿尔法-盖尔综合症的。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-09-01 DOI: 10.7326/ANNALS-26-03644-IM
Stacey Butterfield
{"title":"All about alpha-gal syndrome from early days to now.","authors":"Stacey Butterfield","doi":"10.7326/ANNALS-26-03644-IM","DOIUrl":"10.7326/ANNALS-26-03644-IM","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"IMN95-IMN98"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148863322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In adults with active cancer and suspected PE, the YEARS algorithm was noninferior to CTPA alone for ruling out VTE at 3 mo. 在活动性癌症和疑似PE的成人中,YEARS算法在3个月时排除VTE的效果不逊于单纯的CTPA。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-10-06 DOI: 10.7326/ANNALS-26-03605-JC
Ali Eshaghpour, Wendy Lim
{"title":"In adults with active cancer and suspected PE, the YEARS algorithm was noninferior to CTPA alone for ruling out VTE at 3 mo.","authors":"Ali Eshaghpour, Wendy Lim","doi":"10.7326/ANNALS-26-03605-JC","DOIUrl":"10.7326/ANNALS-26-03605-JC","url":null,"abstract":"<p><strong>Clinical impact ratings: </strong>Emergency Med: [Formula: see text] GIM/FP/GP: [Formula: see text] Oncology: [Formula: see text] Hematology: [Formula: see text].</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"JC117"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149103144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In CKD without diabetes, finerenone vs. placebo slowed kidney function decline over 32 mo. 在没有糖尿病的CKD患者中,芬尼酮和安慰剂在32个月内延缓了肾功能下降。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-10-06 DOI: 10.7326/ANNALS-26-03577-JC
Shubha Ananthakrishnan
{"title":"In CKD without diabetes, finerenone vs. placebo slowed kidney function decline over 32 mo.","authors":"Shubha Ananthakrishnan","doi":"10.7326/ANNALS-26-03577-JC","DOIUrl":"10.7326/ANNALS-26-03577-JC","url":null,"abstract":"<p><strong>Clinical impact ratings: </strong>GIM/FP/GP: [Formula: see text] Nephrology: [Formula: see text].</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"JC115"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149103206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Would You Screen This 26-Year-Old Woman for Cervical Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center. 如何对一位26岁的女性进行宫颈癌筛查?来自贝斯以色列女执事医疗中心的大查房讨论。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-10-13 DOI: 10.7326/ANNALS-26-02904
C Christopher Smith, David Chelmow, Karen M Freund, Risa B Burns
{"title":"How Would You Screen This 26-Year-Old Woman for Cervical Cancer? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.","authors":"C Christopher Smith, David Chelmow, Karen M Freund, Risa B Burns","doi":"10.7326/ANNALS-26-02904","DOIUrl":"10.7326/ANNALS-26-02904","url":null,"abstract":"<p><p>Cervical cancer is the third most common gynecologic cancer, with more than 13 000 new cases diagnosed in 2025. The incidence of and mortality from cervical cancer vary across racial and ethnic groups and in persons living in medically underserved or geographically isolated areas, with half of all cervical cancers occurring in women who are underscreened or have never been screened. Persistent infection with high-risk types of human papillomavirus (HPV) is the most important risk factor for cervical cancer and is associated with nearly all cases. Although genital tract HPV infection is common, most HPV infections are transient, and cervical cancer occurs in only a small portion of patients with HPV. For decades, cervical cancer screening relied on annual cytologic assessment. A growing understanding of the role of HPV infection in the natural progression of cervical cancer has led to updated screening recommendations from the American Cancer Society and the Women's Preventive Services Initiative, as well as a draft update from the U.S. Preventive Services Task Force. These recommendations include primary HPV testing as a preferred screening strategy and include an option for self-collected specimens for HPV testing. Here, 2 experts in this field, a primary care physician and an obstetrics and gynecology physician, debate how to apply these guidelines when screening a patient for cervical cancer. They discuss a range of screening options and consider the challenges of applying these guidelines across different age groups and in patients at increased risk.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1473-1481"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Doctor in the Waiting Room. 医生在候诊室。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 DOI: 10.7326/ANNALS-26-03016
Stephanie Chang
{"title":"The Doctor in the Waiting Room.","authors":"Stephanie Chang","doi":"10.7326/ANNALS-26-03016","DOIUrl":"https://doi.org/10.7326/ANNALS-26-03016","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":"179 10","pages":"1509-1510"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Summary for Patients: An Updated Systematic Review on Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes. 患者总结:关于胰高血糖素样肽-1受体激动剂和辅助激动剂对非糖尿病成年人减肥的有效性和安全性的最新系统综述。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-09-01 DOI: 10.7326/ANNALS-25-05519-PS
{"title":"Summary for Patients: An Updated Systematic Review on Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes.","authors":"","doi":"10.7326/ANNALS-25-05519-PS","DOIUrl":"10.7326/ANNALS-25-05519-PS","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"I15"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148863389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benzodiazepine Prescriptions to Older Adults in the United States, 2015 to 2024. 2015年至2024年美国老年人苯二氮卓类药物处方
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-07-07 DOI: 10.7326/ANNALS-25-05594
Mark Olfson, Fangzhou Xie, Greta Bushnell, Naomi Cruz, Jialiang Hua, Jennifer Miles, Stephen Crystal
{"title":"Benzodiazepine Prescriptions to Older Adults in the United States, 2015 to 2024.","authors":"Mark Olfson, Fangzhou Xie, Greta Bushnell, Naomi Cruz, Jialiang Hua, Jennifer Miles, Stephen Crystal","doi":"10.7326/ANNALS-25-05594","DOIUrl":"10.7326/ANNALS-25-05594","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1514-1519"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148395653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Blood Hemoglobin Concentration and Mortality by Age and Sex : A Prospective Cohort Study. 血液血红蛋白浓度与年龄和性别死亡率之间的关系:一项前瞻性队列研究。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-09-08 DOI: 10.7326/ANNALS-26-00057
Malek Ahmad, John G F Cleland, Pasquale Maffia, Rona J Strawbridge, Naveed Sattar, Jill P Pell, Qiaoling Liu, Jocelyn M Friday, Ahmad Alsaeed, Moustafa I Morsy, Htet Htet Ei Khin, Paul Welsh, Pierpaolo Pellicori
{"title":"Association Between Blood Hemoglobin Concentration and Mortality by Age and Sex : A Prospective Cohort Study.","authors":"Malek Ahmad, John G F Cleland, Pasquale Maffia, Rona J Strawbridge, Naveed Sattar, Jill P Pell, Qiaoling Liu, Jocelyn M Friday, Ahmad Alsaeed, Moustafa I Morsy, Htet Htet Ei Khin, Paul Welsh, Pierpaolo Pellicori","doi":"10.7326/ANNALS-26-00057","DOIUrl":"10.7326/ANNALS-26-00057","url":null,"abstract":"<p><strong>Background: </strong>The 1959 World Health Organization (WHO) definition of anemia is widely used, but its relationship with mortality in the general adult population is uncertain.</p><p><strong>Objective: </strong>To evaluate associations between baseline hemoglobin concentration and long-term mortality by age and sex.</p><p><strong>Design: </strong>Prospective cohort study.</p><p><strong>Setting: </strong>Population-based cohort in the United Kingdom.</p><p><strong>Participants: </strong>502 188 adults (median age, 58 years; 54.4% women) recruited from 2006 to 2010; hemoglobin concentration was measured in 477 876 (95.2%). Analyses were stratified by sex and age (<60 vs. ≥60 years). Median follow-up was 13.6 years.</p><p><strong>Measurements: </strong>Hemoglobin concentration categorized relative to WHO sex-specific thresholds (men, <13.0 g/dL; women, <12.0 g/dL). Outcomes were all-cause, cardiovascular, and cancer mortality.</p><p><strong>Results: </strong>All-cause mortality showed a U-shaped association with hemoglobin concentration, with lowest risk 1 to 3 g/dL above the WHO threshold. In the primary adjusted model, the 10-year standardized cumulative incidence (SCI) was 4.5% in the reference group versus 12.5% among participants more than 2 g/dL below the threshold (absolute risk difference [ARD], +8.1 percentage points; 95% CI, 6.7 to 9.4 percentage points); over the entire follow-up, the adjusted hazard ratio (HR) was 2.87 (CI, 2.54 to 3.25). Among those 0 to 1 g/dL above the threshold, the 10-year SCI was 5.3% (ARD, +0.8 percentage points; CI, 0.7 to 1.0 percentage points) and the adjusted HR was 1.18 (CI, 1.15 to 1.21). Associations were less consistent in women younger than 60 years. Patterns for cardiovascular and cancer mortality were similar at low and borderline concentrations but attenuated at higher concentrations.</p><p><strong>Limitation: </strong>Single baseline hemoglobin concentration measurement; predominantly White population.</p><p><strong>Conclusion: </strong>Mortality was lowest at hemoglobin concentrations 1 to 3 g/dL above current WHO thresholds, with higher mortality below and above this range. These hypothesis-generating findings should not define new thresholds but may inform clinical interpretation and evaluation of borderline hemoglobin concentration values.</p><p><strong>Primary funding source: </strong>None.</p>","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1398-1411"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148904982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to I.M. Matters News: Wrestling with recurrent UTIs. 更正I.M.时事新闻:与复发性尿路感染作斗争。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-09-15 DOI: 10.7326/ANNALS-26-03790-IM
{"title":"Correction to I.M. Matters News: Wrestling with recurrent UTIs.","authors":"","doi":"10.7326/ANNALS-26-03790-IM","DOIUrl":"10.7326/ANNALS-26-03790-IM","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"IMN108"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148966193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Both Paternal and Maternal Nutrition Status Matter: An Exemplar From Folate and Vitamin B12 in Association With Risks for Birth Defects. 父亲和母亲的营养状况都很重要:叶酸和维生素B12与出生缺陷风险相关的一个例子。
IF 17.2 1区 医学
Annals of Internal Medicine Pub Date : 2026-10-01 Epub Date: 2026-09-01 DOI: 10.7326/ANNALS-26-03045
Cuilin Zhang, Jing Zhu
{"title":"Both Paternal and Maternal Nutrition Status Matter: An Exemplar From Folate and Vitamin B<sub>12</sub> in Association With Risks for Birth Defects.","authors":"Cuilin Zhang, Jing Zhu","doi":"10.7326/ANNALS-26-03045","DOIUrl":"10.7326/ANNALS-26-03045","url":null,"abstract":"","PeriodicalId":7932,"journal":{"name":"Annals of Internal Medicine","volume":" ","pages":"1502-1503"},"PeriodicalIF":17.2,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148863284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书